Gilead Sciences Announces $24 Million in Grants to Help End the HIV Epidemic for Everyone, Everywhere Pharmaceutical Investing
AUPH INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
Bristol Myers Squibb Announces New Prescription Drug User Fee Act Goal Date for Reblozyl® Supplemental Biologics License Application Pharmaceutical Investing
AUPH INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
AUPH Equity Alert: ROSEN, Top Ranked Investor Counsel, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
Cardiol Therapeutics to Participate in Cantor Fitzgerald's Virtual Rare Orphan Disease Summit Pharmaceutical Investing
AUPH INVESTOR NOTICE: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
